Narrow search
Showing 1 - 10 of 1,260
Cover Image
What makes more, better? An exploratory study on the effects of firm-level commercial operations attributes on pharmaceutical business performance
Chressanthis, George A.; Eisenstein, Eric M.; Barbro, … - In: Journal of medical marketing : device, diagnostic and … 15 (2015) 1/2, pp. 10-25
Persistent link: https://www.econbiz.de/10011618088
Cover Image
Learning, Sophistication, and the Returns to Advertising : Implications for Differences in Firm Performance
Tadelis, Steve; Hooton, Christopher; Manjeer, Utsav; … - National Bureau of Economic Research - 2023
advertising help answer this question? We present results from a large field experiment on Facebook and Instagram that documents … variance in advertisers' ability to generate returns to advertising. We focus on campaigns aimed at boosting sales and tie … advertising expenses to revenues for each advertiser. We find that spending on advertising led to significant increases in …
Persistent link: https://www.econbiz.de/10014250218
Cover Image
Employee engagement in the pharmaceutical sector in Bangladesh : a case study of pharmaceuticals company
Lewis, Anthony; Thomas, Brychan; Al Amin, Md - In: International journal of Indian culture and business … 13 (2016) 3, pp. 332-357
Persistent link: https://www.econbiz.de/10011665093
Cover Image
Does uncertainty boost exports? : a study on the effect of innovation and marketing capabilities in a small and innovation-intensive sector
Vieira, Jorge; Frade, Rui; Martinho, Filipa; Martinho, … - In: Economies : open access journal 11 (2023) 1, pp. 1-20
evaluation of export performance for the Portuguese pharmaceuticals sector (PPI), before and after a period of considerable …
Persistent link: https://www.econbiz.de/10013500906
Cover Image
Organizational scope and investment : evidence from the drug development strategies and performance of biopharmaceutical firms
Guedj, Ilan; Scharfstein, David - 2004
Persistent link: https://www.econbiz.de/10002481759
Cover Image
Tracing the trajectory of industry leader's drug innovation capability : the Amgen corporation case
Oladapo, Victor; Onyeaso, Godwin - In: Review of business & finance studies : RBFS 4 (2013) 2, pp. 69-77
Persistent link: https://www.econbiz.de/10009741232
Cover Image
Assessment of Financial Performance : A Scrutiny on Beximco Pharmaceutical Ltd
Deb, Santus Kumar - 2020
trends of Beximco. Phamra ltd. Data from secondary sources are obtained, i.e. Beximco Pharmaceuticals Ltd's annual report … displays that CR, RTR, ITR, LAT, and WTR are significant in evaluating Beximco Pharmaceuticals Ltd's financial performance …
Persistent link: https://www.econbiz.de/10012826699
Cover Image
Organizational Scope and Investment : Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms
Guedj, Ilan - 2004
This paper compares the clinical trial strategies and performance of large, established ("mature") biopharmaceutical firms to those of smaller ("early stage") firms that have not yet successfully developed a drug. We study a sample of 235 cancer drug candidates that entered clinical trials...
Persistent link: https://www.econbiz.de/10012467754
Cover Image
Internationalization of innovation and firm performance in the pharmaceutical industry
Zhai, Zhe; Ghosal, Vivek - In: International review of economics & finance : IREF 80 (2022), pp. 882-905
Persistent link: https://www.econbiz.de/10013342769
Cover Image
Impact of R&D activities on the financial performance : empirical evidence from Indian pharmaceutical companies
Nandy, Mithun - In: International journal of pharmaceutical and healthcare … 16 (2022) 2, pp. 182-203
Persistent link: https://www.econbiz.de/10013343552